BUZZ-Perfume sales thrive as U.S. beauty brands struggle with sluggish demand in 2025

Reuters
01/01
BUZZ-Perfume sales thrive as U.S. beauty brands struggle with sluggish demand in 2025

** U.S. beauty sector remained under pressure in 2025 due to tariff-led uncertainty, while focus on prestige brands and younger shoppers revived performance of cosmetics maker Estee Lauder EL.N and retailer Ulta Beauty ULTA.O

** Coty COTY.N, Elf Beauty ELF.N and Bath & Body Works BBWI.N logged the biggest decline since 2018

** COTY grappled with slowing demand for its products and rising competition; it also plans on selling its cosmetics business to focus on more profitable fragrance segment, also faces leadership changes

** Elf Beauty struggled with tariff uncertainty, as about 75% of the cosmetics maker’s global production comes from China

** Ulta Beauty up ~39% this year, driven by steady demand from younger shoppers for its affordable, trendy offerings and celebrity-owned brands

** Luxury beauty brand Estee Lauder shares climbed this year driven by its turnaround efforts focused on strong fragrance sales, improving China demand and supply-chain shifts

** Analysts at Jefferies expect "Still, beauty spending is expected to top 2025 levels next year, driven by demand for prestige brands, Jefferies analysts write in a note

** Brokerage also expects the industry to focus on makeup after several years of fragrance taking centerstage

** *  S&P 500 Personal Care Products industry sub-index .SPLRCPEPR down 0.7% YTD, while broader S&P 500 .SPX is up 17.3%

Companies

RIC

2025 YTD

2024

2023

Ulta Beauty

ULTA.O

39.3%

-11.2%

4.46%

Coty

COTY.N

-55.6%

-43.9%

45.%

Bath & Body Works

BBWI.N

-47.9%

-10.2%

2.4%

Elf Beauty

ELF.N

-38.8%

-13%

161%

Estee Lauder

EL.N

41.2%

-48.7%

-41%

(Reporting by Sanskriti Shekhar and Koyena Das in Bengaluru)

((Sanskriti.Shekhar@thomsonreuters.com))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10